Standard Biotools | FLDM - Sales Revenues


Standard Biotools reported $19.55M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agilent USD 1.86B 123M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Bio-Rad Laboratories USD 653M 1.4M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Illumina USD 1.08B 20M Sep/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Nikon Corporation JPY 154.79B 3.33B Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sony JPY 3.71T 600B Dec/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 800M 29M Sep/2025